Andere talen Deciphera Pharmaceuticals, Inc.

Aandelen

DCPH

US24344T1016

Beurs gesloten - Nasdaq Andere beurzen 21:59:47 04-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
25,56 ^USD	0,00%		+0,20%	+58,46%

03/06	Deciphera Pharmaceuticals kondigt mondelinge presentatie aan van de resultaten van de Motion Pivotal Fase 3-studie van vimseltinib bij patiënten met Tenosynovial Giant Cell Tumor (Tgct) tijdens de 2024 Asco Annual Meeting en online publicatie in de Lancet	CI
10/05	Deciphera Pharmaceuticals, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet	03/06
Deciphera Pharmaceuticals Announces Oral Presentation of Results from Motion Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor At the 2024 Asco Annual Meeting and Online Publication in the Lancet	03/06
Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPH	02/05
North American Morning Briefing : Traders Wait for -2-	01/05
North American Morning Briefing : More Earnings -2-	30/04
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion	30/04
INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Deciphera Pharmaceuticals, Inc. - DCPH	29/04
US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week	29/04
Sector Update: Health Care Stocks Edge Higher Late Afternoon	29/04
Top Midday Gainers	29/04
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading	29/04
Sector Update: Health Care	29/04
Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical	29/04
Shareholder Alert: Ademi LLP investigates whether Deciphera Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with ONO Pharmaceutical Co.	29/04
Deciphera Shares Hit 2-Year High After $2.4 Billion Buyout Offer From ONO Pharma	29/04
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal	29/04
Sector Update: Health Care	29/04
DCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc. Is Fair to Shareholders	29/04
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal	29/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Deciphera Pharmaceuticals, Inc.

Aandelen

DCPH

US24344T1016

Andere talen

Filters